Delivery Order SPE2DB20D2104-SPE2DB25FMVKD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,307.89 to AmerisourceBergen Drug Corp for Fycompa 0.5 mg/ml oral suspension (340ml) on July 18, 2025. This is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, with performance to occur at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Fycompa 2 mg tablets (30-count packaging) with a contract ceiling value of $1,637.80. This firm fixed-price delivery order, which carries an ultimate completion date of September 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award required no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 13, 2025, for the supply of Fycompa 4 mg tablets (30-count units) with a ceiling value of $1,837.44. This firm fixed-price delivery order, which is expected to be completed by February 14, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Fycompa (perampanel) is an oral anticonvulsant medication used...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.95 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Fycompa 0.5 mg/ml oral suspension in a 340 ml unit. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and represents a non-competitive set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,072.56 to AmerisourceBergen Drug Corp for 30 tablets of Fycompa 6 mg on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Fycompa is an antiepileptic medication used to treat partial-onset seizures, reflecting AmerisourceBergen's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for FYCOMPA 0.5 mg/mL oral suspension (340 mL) on July 14, 2025, with a ceiling value of $1,935.66. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. FYCOMPA is an antiepileptic medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of FYCOMPA 12 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $2,152.34. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $1,040.59 to AmerisourceBergen Drug Corp for FYCOMPA 8 mg tablets (30-count packages) on September 12, 2025, with an ultimate completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is a neurological medication used as an adjunctive treatment for epilepsy and seizure...
- The Defense Logistics Agency awarded a delivery order valued at $2,903.46 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of FYCOMPA 0.5 mg/ml oral suspension (340ml). This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procurement procedures. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,224.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for FYCOMPA 2 mg tablets (30-count units) on October 20, 2025, with an ultimate completion date of October 21, 2025. This non-competitive delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. FYCOMPA (perampanel) is an oral antiepileptic medication used in the treatment of seizure disorders, reflecting the Defense Logistics Agency...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMVKDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Fycompa (perampanel) 0.5 mg/ml oral suspension in a 340ml unit, with a ceiling value of $3,176.22. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. Performance will be completed by July 15, 2025, with the place of performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Fycompa is a neurological medication commonly used for seizure management, indicating this procurement supports federal medical supply needs for military and healthcare beneficiaries. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for the Defense Logistics Agency's Medical Supply Chain, providing an extensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's contract awards demonstrate consistent capability to fulfill federal medical procurement requirements through open competition with diverse product offerings ranging from specialty medications to vaccines and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/14/25 |